Yun Jeongseop, Min Ji Sang
Department of Ophthalmology, Kim's Eye Hospital, Konyang University College of Medicine, Seoul, South Korea.
Front Med (Lausanne). 2022 Aug 10;9:893940. doi: 10.3389/fmed.2022.893940. eCollection 2022.
We investigated the change in skin temperature of treated areas during intense pulsed light (IPL) treatment in patients who have meibomian gland dysfunction (MGD) to determine whether there is superficial telangiectatic blood vessel ablation.
The medical records of 90 patients (90 eyes) with MGD who underwent IPL treatment were reviewed. The patients had undergone IPL treatment four times every 4 weeks. Ocular Surface Disease Index (OSDI) scores, dry eye (DE), and MGD parameters were obtained before the first and after the fourth IPL treatments. The skin temperatures of the upper and lower lids were measured before every IPL treatment.
The skin temperatures of the lower lids were 31.89 ± 0.72°C at the first IPL (IPL#1), 30.89 ± 0.63°C at the second IPL (IPL#2), 30.14 ± 0.95°C at the third IPL (IPL#3), and 29.74 ± 0.87°C at the fourth IPL (IPL#4) treatments. The skin temperatures of upper lids were 32.01 ± 0.69°C at IPL#1, 31.13 ± 0.75°C at IPL#2, 30.34 ± 1.07°C at IPL#3, and 29.91 ± 0.76°C at IPL#4. The skin temperature of the upper and lower lids significantly decreased with every IPL treatment. Schirmer 1 test (ST) result was 12.97 ± 10.22 mm before IPL#1 and 14.45 ± 9.99 mm after IPL#4. Tear break-up time (TBUT) was 3.15 ± 1.38 s before IPL#1 and 5.53 ± 2.34 s after IPL#4. Corneal staining scores (CFS) was 1.61 ± 3.09 before IPL#1 and 0.50 ± 0.78 after IPL#4. Lipid layer thickness (LLT) was 71.88 ± 26.34 nm before IPL#1 and 68.38 ± 24.16 nm after IPL#4. Lid margin abnormality score (LAS) was 1.96 ± 0.62 before IPL#1 and 0.86 ± 0.67 after IPL#4. Meibum expressibility (ME) was 1.67 ± 0.87 before IPL#1 and 1.03 ± 1.67 after IPL#4. Meibum quality (MQ) was 18.18 ± 6.34 before IPL#1 and 10.16 ± 5.48 after IPL#4. OSDI was 35.38 ± 19.97 before IPL#1 and 15.48 ± 34.32 after IPL#4. OSDI scores, DE, and MGD parameters significantly improved after the fourth IPL treatment but not ST and LLT.
Our study showed that the occurrence of superficial telangiectatic vessels were indirectly reduced by the decrease in skin temperature accompanying IPL treatments in patients with MGD.
我们研究了睑板腺功能障碍(MGD)患者在强脉冲光(IPL)治疗期间治疗区域皮肤温度的变化,以确定是否存在浅表毛细血管扩张性血管消融。
回顾了90例(90只眼)接受IPL治疗的MGD患者的病历。患者每4周接受4次IPL治疗。在第一次IPL治疗前和第四次IPL治疗后获取眼表疾病指数(OSDI)评分、干眼(DE)和MGD参数。在每次IPL治疗前测量上下眼睑的皮肤温度。
下眼睑皮肤温度在第一次IPL(IPL#1)时为31.89±0.72°C,第二次IPL(IPL#2)时为30.89±0.63°C,第三次IPL(IPL#3)时为30.14±0.95°C,第四次IPL(IPL#4)治疗时为29.74±0.87°C。上眼睑皮肤温度在IPL#1时为32.01±0.69°C,IPL#2时为31.13±0.75°C,IPL#3时为30.34±1.07°C,IPL#4时为29.91±0.76°C。每次IPL治疗后,上下眼睑的皮肤温度均显著降低。Schirmer 1试验(ST)结果在IPL#1前为12.97±10.22mm,IPL#4后为14.45±9.99mm。泪膜破裂时间(TBUT)在IPL#1前为3.15±1.38秒,IPL#4后为5.53±2.34秒。角膜染色评分(CFS)在IPL#1前为1.61±3.09,IPL#4后为0.50±0.78。脂质层厚度(LLT)在IPL#1前为71.88±